Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials

References

• AbuMweis, S., S. Jew, R. Tayyem, and L. Agraib. 2018. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: A meta-analysis of randomised placebo-control human clinical trials. Journal of Human Nutrition and Dietetics: The Official Journal of the British Dietetic Association 31 (1):67–84. doi: 10.1111/jhn.12493.
   PubMed Web of Science ®Google Scholar
• Akrami, A., F. Nikaein, S. Babajafari, S. Faghih, and H. Yarmohammadi. 2018. Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome. Journal of Clinical Lipidology 12 (1):70–7. doi: 10.1016/j.jacl.2017.11.004.
   PubMed Web of Science ®Google Scholar
• Akrami, A., E. Makiabadi, M. Askarpour, K. Zamani, A. Hadi, A. Mokari-Yamchi, S. Babajafari, S. Faghih, and A. Hojhabrimanesh. 2020. A comparative study of the effect of flaxseed oil and sunflower oil on the coagulation score, selected oxidative and inflammatory parameters in metabolic syndrome patients. Clinical Nutrition Research 9 (1):63–72. doi: 10.7762/cnr.2020.9.1.63.
   PubMedGoogle Scholar
• Albert, B. B., D. Cameron-Smith, P. L. Hofman, and W. S. Cutfield. 2013. Oxidation of marine omega-3 supplements and human health. BioMed Research International 2013:464921. doi: 10.1155/2013/464921.
   PubMed Web of Science ®Google Scholar
• Balk, E. M., A. H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, and J. Lau. 2006. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 189 (1):19–30. doi: 10.1016/j.atherosclerosis.2006.02.012.
   PubMed Web of Science ®Google Scholar
• Baxheinrich, A., B. Stratmann, Y. H. Lee-Barkey, D. Tschoepe, and U. Wahrburg. 2012. Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. The British Journal of Nutrition 108 (4):682–91. doi: 10.1017/s0007114512002875.
   PubMed Web of Science ®Google Scholar
• Bays, H. E., C. M. Ballantyne, R. A. Braeckman, W. G. Stirtan, R. T. J. Doyle, S. Philip, P. N. Soni, and R. A. Juliano. 2015. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects upon high-sensitivity C-reactive protein and lipid parameters in patients with metabolic syndrome. Metabolic Syndrome and Related Disorders 13 (6):239–47. doi: 10.1089/met.2014.0137.
   PubMed Web of Science ®Google Scholar
• Bellien, J., E. Bozec, F. Bounoure, H. Khettab, J. Malloizel-Delaunay, M. Skiba, M. Iacob, N. Donnadieu, A. Coquard, B. Morio, et al. 2022. The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: A randomized, placebo-controlled, double-blind study. The American Journal of Clinical Nutrition 115 (3):694–704. doi: 10.1093/ajcn/nqab374.
   PubMed Web of Science ®Google Scholar
• Borghi, C., and A. Cicero. 2007. Blood pressure modulating properties of omega3 polyunsaturated fatty acids (PUFA). High Blood Pressure & Cardiovascular Prevention 14 (2):55–61. doi: 10.2165/00151642-200714020-00001.
   Google Scholar
• Calder, P. C. 2020. Omega-3 (n-3) polyunsaturated fatty acids and inflammation: From membrane to nucleus and from bench to bedside. Proceedings of the Nutrition Society 79 (4):404–16. doi: 10.1017/S0029665120007077.
   Web of Science ®Google Scholar
• Chen, R., E. Corona, M. Sikora, J. T. Dudley, A. A. Morgan, A. Moreno-Estrada, G. B. Nilsen, D. Ruau, S. E. Lincoln, C. D. Bustamante, et al. 2012. Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genetics 8 (4):e1002621. doi: 10.1371/journal.pgen.1002621.
   PubMed Web of Science ®Google Scholar
• Coelho, O. G. L., B. P. da Silva, D. Rocha, L. L. Lopes, and R. C. G. Alfenas. 2017. Polyunsaturated fatty acids and type 2 diabetes: Impact on the glycemic control mechanism. Critical Reviews in Food Science and Nutrition 57 (17):3614–9. doi: 10.1080/10408398.2015.1130016.
   PubMed Web of Science ®Google Scholar
• Dewell, A., F. F. Marvasti, W. S. Harris, P. Tsao, and C. D. Gardner. 2011. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. The Journal of Nutrition 141 (12):2166–71. doi: 10.3945/jn.111.142240.
   PubMed Web of Science ®Google Scholar
• Durrington, P. N., D. Bhatnagar, M. I. Mackness, J. Morgan, K. Julier, M. A. Khan, and M. France. 2001. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart (British Cardiac Society) 85 (5):544–8. doi: 10.1136/heart.85.5.544.
   PubMed Web of Science ®Google Scholar
• Ebrahimi, M., M. Ghayour-Mobarhan, S. Rezaiean, M. Hoseini, S. M. Parizade, F. Farhoudi, S. J. Hosseininezhad, S. Tavallaei, A. Vejdani, M. Azimi-Nezhad, et al. 2009. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiologica 64 (3):321–7. doi: 10.2143/ac.64.3.2038016.
   PubMed Web of Science ®Google Scholar
• Egert, S., A. Baxheinrich, Y. H. Lee-Barkey, D. Tschoepe, U. Wahrburg, and B. Stratmann. 2014. Effects of an energy-restricted diet rich in plant-derived α-linolenic acid on systemic inflammation and endothelial function in overweight-to-obese patients with metabolic syndrome traits. The British Journal of Nutrition 112 (8):1315–22. doi: 10.1017/s0007114514002001.
   PubMed Web of Science ®Google Scholar
• Emadian, A., C. Y. England, and J. L. Thompson. 2017. Dietary intake and factors influencing eating behaviours in overweight and obese South Asian men living in the UK: Mixed method study. BMJ Open 7 (7):e016919. doi: 10.1136/bmjopen-2017-016919.
   PubMed Web of Science ®Google Scholar
• Farhangi, M. A., P. Dehghan, V. Musazadeh, M. Kavyani, and P. Maleki. 2022. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Journal of Functional Foods 92:105074. doi: 10.1016/j.jff.2022.105074.
   Web of Science ®Google Scholar
• Gajos, G., J. Zalewski, M. Mostowik, E. Konduracka, J. Nessler, and A. Undas. 2014. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 24 (4):434–9. doi: 10.1016/j.numecd.2013.09.011.
   PubMed Web of Science ®Google Scholar
• Galland, L. 2010. Diet and inflammation. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition 25 (6):634–40. doi: 10.1177/0884533610385703.
   PubMed Web of Science ®Google Scholar
• Gholamhosseini, S., E. Nematipour, A. Djazayery, M. H. Javanbakht, F. Koohdani, M. Zareei, and M. Djalali. 2015. ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: A randomized, double-blind placebo-controlled study. Nutrition (Burbank, Los Angeles County, Calif.) 31 (3):480–4. doi: 10.1016/j.nut.2014.09.010.
   PubMed Web of Science ®Google Scholar
• Grenon, S. M., C. D. Owens, E. V. Nosova, M. Hughes-Fulford, H. F. Alley, K. Chong, S. Perez, P. K. Yen, J. Boscardin, J. Hellmann, et al. 2015. Short-Term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I trial). Journal of the American Heart Association 4 (8):e002034. doi: 10.1161/jaha.115.002034.
   PubMed Web of Science ®Google Scholar
• Grundt, H., D. W. Nilsen, M. A. Mansoor, Ø. Hetland, and A. Nordøy. 2003. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: No effect on endothelial adhesion properties. Pathophysiology of Haemostasis and Thrombosis 33 (2):88–95. doi: 10.1159/000073852.
   PubMedGoogle Scholar
• Haidari, F., M. Tavakoli, H. Heybar, B. Helli, and M. Mohammadshahi. 2015. The effect of omega-3 on the level of serum lipid profile, adipocytokines, and indicator of vascular inflammation in patients diagnosed with myocardial infarction. Journal of Babol University of Medical Sciences 17 (4):7–17.
   Google Scholar
• Heydari, B., S. Abdullah, J. V. Pottala, R. Shah, S. Abbasi, D. Mandry, S. A. Francis, H. Lumish, B. B. Ghoshhajra, U. Hoffmann, et al. 2016. Effect of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial. Circulation 134 (5):378–91. doi: 10.1161/circulationaha.115.019949.
   PubMed Web of Science ®Google Scholar
• Higgins, J., and S. Green. 2011. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. Cochrane Collaboration: 33–49. https://training.cochrane.org/handbook/PDF/v6.2.
   Google Scholar
• Hoogeveen, E. K., J. M. Geleijnse, D. Kromhout, and E. J. Giltay. 2014. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: The Alpha Omega Trial. European Journal of Preventive Cardiology 21 (11):1429–36. doi: 10.1177/2047487313494295.
   PubMed Web of Science ®Google Scholar
• Isomaa, B., P. Almgren, T. Tuomi, B. Forsén, K. Lahti, M. Nissén, M. R. Taskinen, and L. Groop. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (4):683–9. doi: 10.2337/diacare.24.4.683.
   PubMed Web of Science ®Google Scholar
• Jang, H., and K. Park. 2020. Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta-analysis. Clinical Nutrition (Edinburgh, Scotland) 39 (3):765–73. doi: 10.1016/j.clnu.2019.03.032.
   PubMed Web of Science ®Google Scholar
• Kavyani, Z., M. Vali, F. Soroor, H. Amir, D. Parvin, and S. Bahareh. 2022. Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: An umbrella meta-analysis. International Immunopharmacology 111:109104. doi: 10.1016/j.intimp.2022.109104.
   PubMed Web of Science ®Google Scholar
• Kohashi, K., A. Nakagomi, Y. Saiki, T. Morisawa, M. Kosugi, Y. Kusama, H. Atarashi, and W. Shimizu. 2014. Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia. Journal of Atherosclerosis and Thrombosis 21 (7):712–29. doi: 10.5551/jat.21022.
   PubMed Web of Science ®Google Scholar
• Lee, K. W., A. D. Blann, and G. Y. Lip. 2006. Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thrombosis Research 118 (3):305–12. doi: 10.1016/j.thromres.2005.07.018.
   PubMed Web of Science ®Google Scholar
• Liu, X., Y. Xue, C. Liu, Q. Lou, J. Wang, T. Yanagita, C. Xue, and Y. Wang. 2013. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids in Health and Disease 12:109. doi: 10.1186/1476-511x-12-109.
   PubMed Web of Science ®Google Scholar
• Lorente-Cebrián, S., A. G. Costa, S. Navas-Carretero, M. Zabala, J. A. Martínez, and M. J. Moreno-Aliaga. 2013. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: A review of the evidence. Journal of Physiology and Biochemistry 69 (3):633–51. doi: 10.1007/s13105-013-0265-4.
   PubMed Web of Science ®Google Scholar
• Mackay, I., I. Ford, F. Thies, S. Fielding, P. Bachoo, and J. Brittenden. 2012. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease. Atherosclerosis 221 (2):514–20. doi: 10.1016/j.atherosclerosis.2011.12.041.
   PubMed Web of Science ®Google Scholar
• Madsen, T., J. H. Christensen, and E. B. Schmidt. 2007. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: A placebo-controlled randomized study. European Journal of Nutrition 46 (7):428–30. doi: 10.1007/s00394-007-0673-8.
   PubMed Web of Science ®Google Scholar
• Mahmudiono, T., S. A. Jasim, Y. S. Karim, D. O. Bokov, W. K. Abdelbasset, K. S. Akhmedov, G. Yasin, L. Thangavelu, Y. F. Mustafa, S. Shoukat, et al. 2022. The effect of flaxseed oil consumtion on blood pressure among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials. Phytotherapy Research: PTR 36 (10):3766–73. doi: 10.1002/ptr.7566.
   PubMed Web of Science ®Google Scholar
• Makarewicz-Wujec, M., G. Parol, A. Parzonko, and M. Kozłowska-Wojciechowska. 2017. Supplementation with omega-3 acids after myocardial infarction and modification of inflammatory markers in light of the patients’ diet: A preliminary study. Kardiologia Polska 75 (7):674–81. doi: 10.5603/KP.a2017.0072.
   PubMed Web of Science ®Google Scholar
• Mansoori, A., G. Sotoudeh, M. Djalali, M. R. Eshraghian, M. Keramatipour, E. Nasli-Esfahani, F. Shidfar, E. Alvandi, O. Toupchian, and F. Koohdani. 2015. Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial. Journal of Clinical Lipidology 9 (6):770–7. doi: 10.1016/j.jacl.2015.08.007.
   PubMed Web of Science ®Google Scholar
• Mehra, M. R., C. J. Lavie, H. O. Ventura, and R. V. Milani. 2006. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 25 (7):834–8. doi: 10.1016/j.healun.2006.03.005.
   PubMed Web of Science ®Google Scholar
• Moertl, D., A. Hammer, S. Steiner, R. Hutuleac, K. Vonbank, and R. Berger. 2011. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: A double-blind, placebo-controlled, 3-arm study. American Heart Journal 161 (5):915.e1-9–915.e9. doi: 10.1016/j.ahj.2011.02.011.
   PubMed Web of Science ®Google Scholar
• Moertl, D., R. Berger, A. Hammer, R. Hutuleac, R. Koppensteiner, C. W. Kopp, and S. Steiner. 2011. Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thrombosis and Haemostasis 106 (3):457–65. doi: 10.1160/th11-03-0169.
   PubMed Web of Science ®Google Scholar
• Mori, T. A. 2014. Omega-3 fatty acids and cardiovascular disease: Epidemiology and effects on cardiometabolic risk factors. Food & Function 5 (9):2004–19. doi: 10.1039/c4fo00393d.
   PubMed Web of Science ®Google Scholar
• Mortazavi, A., E. Nematipoor, M. Djalali, S. A. Keshavarz, S. Samavat, M. Zarei, and M. H. Javanbakht. 2018. The effect of omega-3 fatty acids on serum apelin levels in cardiovascular disease: A randomized, double-blind, placebo-controlled trial. Reports of Biochemistry & Molecular Biology 7 (1):59–66.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., K. C. Maki, H. E. Bays, F. Aguilera, G. Gould, R. A. Hegele, P. M. Moriarty, J. G. Robinson, P. Shi, J. F. Tur, et al. 2022. effectiveness of a novel ω-3 krill oil agent in patients with severe hypertriglyceridemia: A randomized clinical trial. JAMA Network Open 5 (1):e2141898. doi: 10.1001/jamanetworkopen.2021.41898.
   PubMed Web of Science ®Google Scholar
• Musazadeh, V., P. Dehghan, and M. Khoshbaten. 2022. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: A randomized, controlled trial. European Journal of Gastroenterology & Hepatology 34 (5):537–45. doi: 10.1097/MEG.0000000000002297.
   PubMed Web of Science ®Google Scholar
• Musazadeh, V., Z. Kavyani, B. Naghshbandi, P. Dehghan, and M. Vajdi. 2022. The beneficial effects of omega-3 polyunsaturated fatty acids on controlling blood pressure: An umbrella meta-analysis. Frontiers in Nutrition 9:985451. doi: 10.3389/fnut.2022.985451.
   PubMed Web of Science ®Google Scholar
• Musazadeh, V., J. Jafarzadeh, M. Keramati, M. Zarezadeh, M. Ahmadi, Z. Farrokhian, and A. Ostadrahimi. 2021. Flaxseed oil supplementation augments antioxidant capacity and alleviates oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine: ECAM 2021:4438613. doi: 10.1155/2021/4438613.
   PubMed Web of Science ®Google Scholar
• Myhre, P. L., A. A. Kalstad, S. H. Tveit, K. Laake, E. B. Schmidt, P. Smith, D. W. T. Nilsen, A. Tveit, S. Solheim, H. Arnesen, et al. 2022. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. Journal of Internal Medicine 291 (5):637–47. doi: 10.1111/joim.13442.
   PubMed Web of Science ®Google Scholar
• Natto, Z. S., W. Yaghmoor, H. K. Alshaeri, and T. E. Van Dyke. 2019. Omega-3 fatty acids effects on inflammatory biomarkers and lipid profiles among diabetic and cardiovascular disease patients: A systematic review and meta-analysis. Scientific Reports 9 (1):18867. doi: 10.1038/s41598-019-54535-x.
   PubMedGoogle Scholar
• Nigam, A., M. Talajic, D. Roy, S. Nattel, J. Lambert, A. Nozza, P. Jones, V. R. Ramprasath, G. O'Hara, S. Kopecky, et al. 2014. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. Journal of the American College of Cardiology 64 (14):1441–8. doi: 10.1016/j.jacc.2014.07.956.
   PubMed Web of Science ®Google Scholar
• Nodari, S., M. Metra, G. Milesi, A. Manerba, B. M. Cesana, M. Gheorghiade, and L. Dei Cas. 2009. The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovascular Drugs and Therapy 23 (1):5–15. doi: 10.1007/s10557-008-6142-7.
   PubMed Web of Science ®Google Scholar
• Nodari, S., M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, and L. Dei Cas. 2011. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. Journal of the American College of Cardiology 57 (7):870–9. doi: 10.1016/j.jacc.2010.11.017.
   PubMed Web of Science ®Google Scholar
• Oikonomou, E., G. Vogiatzi, D. Karlis, G. Siasos, C. Chrysohoou, T. Zografos, G. Lazaros, S. Tsalamandris, K. Mourouzis, G. Georgiopoulos, et al. 2019. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients. Clinical Nutrition (Edinburgh, Scotland) 38 (3):1188–97. doi: 10.1016/j.clnu.2018.04.017.
   PubMed Web of Science ®Google Scholar
• Poppitt, S. D., C. A. Howe, F. E. Lithander, K. M. Silvers, R. B. Lin, J. Croft, Y. Ratnasabapathy, R. A. Gibson, and C. S. Anderson. 2009. Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: A randomized, controlled trial. Stroke 40 (11):3485–92. doi: 10.1161/strokeaha.109.555136.
   PubMed Web of Science ®Google Scholar
• Ramirez, J. L., W. J. Gasper, S. A. Khetani, G. J. Zahner, N. K. Hills, P. T. Mitchell, B. E. Sansbury, M. S. Conte, M. Spite, and S. M. Grenon. 2019. Fish oil increases specialized pro-resolving lipid mediators in PAD (The OMEGA-PAD II trial). The Journal of Surgical Research 238:164–74. doi: 10.1016/j.jss.2019.01.038.
   PubMed Web of Science ®Google Scholar
• Reis, G. J., D. I. Silverman, T. M. Boucher, M. E. Sipperly, G. L. Horowitz, F. M. Sacks, and R. C. Pasternak. 1990. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. The American Journal of Cardiology 66 (17):1171–5. doi: 10.1016/0002-9149(90)91093-l.
   PubMed Web of Science ®Google Scholar
• Roth, G. A., G. A. Mensah, and V. Fuster. 2020. The global burden of cardiovascular diseases and risks: A compass for global action. Journal of the American College of Cardiology 76 (25):2980–1. doi: 10.1016/j.jacc.2020.11.021.
   PubMed Web of Science ®Google Scholar
• Saklayen, M. G. 2018. The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports 20 (2):12. doi: 10.1007/s11906-018-0812-z.
   PubMed Web of Science ®Google Scholar
• Saleh-Ghadimi, S., S. Kheirouri, A. Golmohammadi, J. Moludi, H. Jafari-Vayghan, and M. Alizadeh. 2019. Effect of flaxseed oil supplementation on anthropometric and metabolic indices in patients with coronary artery disease: A double-blinded randomized controlled trial. Journal of Cardiovascular and Thoracic Research 11 (2):152–60. doi: 10.15171/jcvtr.2019.26.
   PubMed Web of Science ®Google Scholar
• Samavat, S., M. Djalali, E. Nematipour, M. R. Eshraghian, M. Zarei, S. Gholamhoseini, and M. H. Javanbakht. 2018. Omega-3 fatty acid modifies serum HSP 70 and hs-CRP in patients with cardiovascular disease: Randomized double‐blind placebo-controlled trial. Acta Medica Iranica 56 (6):379–85.
   Google Scholar
• Samavat, S., M. H. Javanbakht, E. Nematipour, M. Zarei, N. M. Honarvar, A. Ramezani, H. Mohammadi, and M. Djalali. 2019. The effect of omega-3 supplementation on serum levels of YKL-40, BMP-4, and ox-LDL in men with coronary artery disease: A randomized double-blind placebo-controlled trial. Progress in Nutrition 21:288–96. doi: 10.23751/pn.v21i1-S.6135.
   Web of Science ®Google Scholar
• Satoh, N., A. Shimatsu, K. Kotani, N. Sakane, K. Yamada, T. Suganami, H. Kuzuya, and Y. Ogawa. 2007. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 30 (1):144–6. doi: 10.2337/dc06-1179.
   PubMed Web of Science ®Google Scholar
• Satoh, N., A. Shimatsu, K. Kotani, A. Himeno, T. Majima, K. Yamada, T. Suganami, and Y. Ogawa. 2009. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. Hypertension Research: Official Journal of the Japanese Society of Hypertension 32 (11):1004–8. doi: 10.1038/hr.2009.145.
   PubMed Web of Science ®Google Scholar
• Sawada, T., H. Tsubata, N. Hashimoto, M. Takabe, T. Miyata, K. Aoki, S. Yamashita, S. Oishi, T. Osue, K. Yokoi, et al. 2016. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial. Cardiovascular Diabetology 15 (1):121. doi: 10.1186/s12933-016-0437-y.
   PubMedGoogle Scholar
• Shamseer, L., D. Moher, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, and L. A. Stewart. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ Clinical Research 349 (jan02 1):g7647–g7647. doi: 10.1136/bmj.g7647.
   PubMed Web of Science ®Google Scholar
• Shearer, G. C., J. V. Pottala, S. N. Hansen, V. Brandenburg, and W. S. Harris. 2012. Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: A randomized controlled trial. Journal of Lipid Research 53 (11):2429–35. doi: 10.1194/jlr.P022392.
   PubMed Web of Science ®Google Scholar
• Sherling, D. H., P. Perumareddi, and C. H. Hennekens. 2017. Metabolic Syndrome. Journal of Cardiovascular Pharmacology and Therapeutics 22 (4):365–7. doi: 10.1177/1074248416686187.
   PubMed Web of Science ®Google Scholar
• Simão, A. N., M. A. Lozovoy, L. D. Bahls, H. K. Morimoto, T. N. Simão, T. Matsuo, and I. Dichi. 2012. Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: Role of adiponectin and nitric oxide. The British Journal of Nutrition 108 (8):1435–42. doi: 10.1017/s0007114511006921.
   PubMed Web of Science ®Google Scholar
• Simão, A. N., M. A. Lozovoy, and I. Dichi. 2014. Effect of soy product kinako and fish oil on serum lipids and glucose metabolism in women with metabolic syndrome. Nutrition (Burbank, Los Angeles County, Calif.) 30 (1):112–5. doi: 10.1016/j.nut.2013.05.024.
   PubMed Web of Science ®Google Scholar
• Suzuki-Kemuriyama, N., T. Matsuzaka, M. Kuba, H. Ohno, S. I. Han, Y. Takeuchi, M. Isaka, K. Kobayashi, H. Iwasaki, S. Yatoh, et al. 2016. Different effects of eicosapentaenoic and docosahexaenoic acids on atherogenic high-fat diet-induced non-alcoholic fatty liver disease in mice. PloS One 11 (6):e0157580. doi: 10.1371/journal.pone.0157580.
   PubMed Web of Science ®Google Scholar
• Tamtaji, O. R., A. Milajerdi, Ž. Reiner, E. Dadgostar, E. Amirani, Z. Asemi, L. Mirsafaei, M. A. Mansournia, P. M. Dana, F. Sadoughi, et al. 2020. Effects of flaxseed oil supplementation on biomarkers of inflammation and oxidative stress in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 40:27–33. doi: 10.1016/j.clnesp.2020.09.017.
   PubMed Web of Science ®Google Scholar
• Tang, W., Y. Wang, F. Xu, W. Fan, Y. Zhang, K. Fan, W. Wang, Y. Zhang, and C. Zhang. 2020. Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome. Brain, Behavior, and Immunity 88:529–34. doi: 10.1016/j.bbi.2020.04.034.
   PubMed Web of Science ®Google Scholar
• Tardivo, A. P., J. Nahas-Neto, C. L. Orsatti, F. B. Dias, P. F. Poloni, E. B. Schmitt, and E. A. Nahas. 2015. Effects of omega-3 on metabolic markers in postmenopausal women with metabolic syndrome. Climacteric: The Journal of the International Menopause Society 18 (2):290–8. doi: 10.3109/13697137.2014.981521.
   PubMed Web of Science ®Google Scholar
• Terry, P. D., T. E. Rohan, and A. Wolk. 2003. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: A review of the epidemiologic evidence. The American Journal of Clinical Nutrition 77 (3):532–43. doi: 10.1093/ajcn/77.3.532.
   PubMed Web of Science ®Google Scholar
• Tousoulis, D., A. Plastiras, G. Siasos, E. Oikonomou, A. Verveniotis, E. Kokkou, K. Maniatis, N. Gouliopoulos, A. Miliou, T. Paraskevopoulos, et al. 2014. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis 232 (1):10–6. doi: 10.1016/j.atherosclerosis.2013.10.014.
   PubMed Web of Science ®Google Scholar
• Venturini, D., A. N. Simão, M. R. Urbano, and I. Dichi. 2015. Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome. Nutrition (Burbank, Los Angeles County, Calif.) 31 (6):834–40. doi: 10.1016/j.nut.2014.12.016.
   PubMed Web of Science ®Google Scholar
• Venugopal, S. K., S. Devaraj, and I. Jialal. 2005. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Current Opinion in Nephrology and Hypertension 14 (1):33–7. doi: 10.1097/00041552-200501000-00006.
   PubMed Web of Science ®Google Scholar
• Von Schacky, C., P. Angerer, W. Kothny, K. Theisen, and H. Mudra. 1999. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 130 (7):554–62. doi: 10.7326/0003-4819-130-7-199904060-00003.
   PubMed Web of Science ®Google Scholar
• Wadhera, R. K., D. L. Steen, I. Khan, R. P. Giugliano, and J. M. Foody. 2016. A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality. Journal of Clinical Lipidology 10 (3):472–89. doi: 10.1016/j.jacl.2015.11.010.
   PubMed Web of Science ®Google Scholar
• Wang, H., Q. Li, Y. Zhu, and X. Zhang. 2021. Omega-3 Polyunsaturated Fatty Acids: Versatile Roles in Blood Pressure Regulation. Antioxidants & Redox Signaling 34 (10):800–10. doi: 10.1089/ars.2020.8108.
   PubMed Web of Science ®Google Scholar
• Wang, M., X. Hou, W. Hu, L. Chen, and S. Chen. 2019. Serum lipid and lipoprotein levels of middle-aged and elderly Chinese men and women in Shandong Province. Lipids in Health and Disease 18 (1):58. doi: 10.1186/s12944-019-1000-0.
   PubMedGoogle Scholar
• Wei, Y., Y. Meng, N. Li, Q. Wang, and L. Chen. 2021. The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: A systematic review and meta-analysis. Food & Function 12 (1):30–40. doi: 10.1039/d0fo01976c.
   PubMed Web of Science ®Google Scholar
• Wurm, R., L. Schrutka, A. Hammer, D. Moertl, R. Berger, N. Pavo, I. M. Lang, G. Goliasch, M. Huelsmann, and K. Distelmaier. 2018. Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure. European Journal of Clinical Investigation 48 (9):e12998. doi: 10.1111/eci.12998.
   PubMed Web of Science ®Google Scholar
• Yang, B., M. Q. Shi, Z. H. Li, L. Shi, A. M. Wang, X. J. Guo, and D. Li. 2019. Effects of n-3 fatty acid supplements on cardiometabolic profiles in hypertensive patients with abdominal obesity in Inner Mongolia: A randomized controlled trial. Food & Function 10 (3):1661–70. doi: 10.1039/c8fo01707g.
   PubMed Web of Science ®Google Scholar
• Yang, Y., N. Lu, D. Chen, L. Meng, Y. Zheng, and R. Hui. 2012. Effects of n-3 PUFA supplementation on plasma soluble adhesion molecules: A meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 95 (4):972–80. doi: 10.3945/ajcn.111.025924.
   PubMed Web of Science ®Google Scholar
• Yue, H., B. Qiu, M. Jia, W. Liu, X. F. Guo, N. Li, Z. X. Xu, F. L. Du, T. Xu, and D. Li. 2021. Effects of α-linolenic acid intake on blood lipid profiles: a systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 61 (17):2894–910. doi: 10.1080/10408398.2020.1790496.
   PubMed Web of Science ®Google Scholar
• Yusof, H. M., A. L. Cawood, R. Ding, J. A. Williams, F. L. Napper, C. P. Shearman, R. F. Grimble, S. P. Payne, and P. C. Calder. 2013. Limited impact of 2 g/day omega-3 fatty acid ethyl esters (Omacor®) on plasma lipids and inflammatory markers in patients awaiting carotid endarterectomy. Marine Drugs 11 (9):3569–81. doi: 10.3390/md11093569.
   PubMed Web of Science ®Google Scholar
• Zamanian, A., R. Zarrin, S. Faraji, P. Ayramloy, and B. R. Darabad. 2020. The effect of omega-3 fatty acids supplementation on the improvement of metabolic syndrome in patients with ischemic heart disease: A double-blind, randomised, placebo-controlled trial. Journal of Clinical and Diagnostic RESEARCH 14 (11):OC09–OC13. doi: 10.7860/JCDR/2020/45490.14187.
   Web of Science ®Google Scholar
• Zhang, H. J., X. Gao, X. F. Guo, K. L. Li, S. Li, A. J. Sinclair, and D. Li. 2021. Effects of dietary eicosapentaenoic acid and docosahexaenoic acid supplementation on metabolic syndrome: A systematic review and meta-analysis of data from 33 randomized controlled trials. Clinical Nutrition (Edinburgh, Scotland) 40 (7):4538–50. doi: 10.1016/j.clnu.2021.05.025.
   PubMed Web of Science ®Google Scholar
• Zhao, Y. T., L. Shao, L. L. Teng, B. Hu, Y. Luo, X. Yu, D. F. Zhang, and H. Zhang. 2009. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. The Journal of International Medical Research 37 (6):1831–41. doi: 10.1177/147323000903700619.
   PubMed Web of Science ®Google Scholar
• Zhou, Q., Z. Zhang, P. Wang, B. Zhang, C. Chen, C. Zhang, and Y. Su. 2020. EPA + DHA, but not ALA, improved lipids and inflammation status in hypercholesterolemic adults: A randomized, double-blind, placebo-controlled trial. Molecular Nutrition & Food Research 64 (7):e2070012. doi: 10.1002/mnfr.202070012.
   PubMed Web of Science ®Google Scholar